Plasma Donation Info

Recognizing World Hemophilia Day: April 17th, 2024

Apr 16, 2024
Recognizing World Hemophilia Day: April 17th, 2024
Written by BioLife Medical Affairs Team

For World Hemophilia Day on April 17th, it's crucial to recognize the significant role that plasma-derived therapies (PDT) and plasma donors, such as those at BioLife, play in supporting individuals with blood clotting disorders like Hemophilia A and Von Willebrand Disease.

What are plasma-derived therapies? 

Plasma-derived therapies are medical treatments created from the plasma portion of human blood, which contains essential proteins and antibodies. These therapies are crucial for treating various disorders, including immune deficiencies, and clotting disorders like hemophilia.

What is Hemophilia?

Hemophilia is a genetic disorder characterized by a deficiency or absence of specific clotting factors in the blood, which impairs the blood's ability to clot properly.

How is donated plasma used for Hemophilia treatments?

Plasma, the liquid component of blood, contains various clotting factors, which are essential for normal blood clotting. Individuals with hemophilia have deficiencies in these clotting factors, making it difficult to form a stable clot during bleeding episodes. Plasma-derived clotting factor concentrates, processed from donated human plasma, are used to supplement these missing or deficient clotting factors. These concentrates specifically isolate and enhance the necessary clotting factors needed by individuals with hemophilia.

 

By infusing plasma-derived clotting factor concentrates, individuals with hemophilia can restore the missing or deficient clotting factors in their blood. This helps promote proper blood clotting and prevents or stops bleeding episodes. The specific clotting factors administered depend on the type and severity of hemophilia the individual has. Read Mitchel’s story here.

 

In summary, plasma-derived therapies (PDT) and plasma donors, such as those at BioLife, play a vital role in greatly improving the quality of life by providing individuals with hemophilia the necessary clotting factors that are deficient in their blood. Utilizing plasma for hemophilia treatments has become a cornerstone in managing this challenging condition, offering hope and improved quality of life to those affected by bleeding disorders.

 

Thank you for helping us give hope to people with Hemophilia and other rare diseases!

 

Donating for the first time? Here are 8 Tips for New Plasma Donors From Experienced Plasma Donors and you can find your closest BioLife plasma donation center here.